Fuad El-Hibri
Fuad El-Hibri (pronunciation: foo-ad el-hee-bree) is a prominent figure in the field of biotechnology and vaccinology. He is best known as the founder and executive chairman of Emergent BioSolutions, a multinational biopharmaceutical company dedicated to the development, manufacture, and commercialization of vaccines and therapeutics.
Etymology
The name Fuad is of Arabic origin and means "heart", while El-Hibri is derived from the Arabic word "hibr", meaning "ink" or "scholar".
Career
Fuad El-Hibri started his career in the banking sector, working for Citibank and later for Booz Allen Hamilton, a management consulting firm. In 1998, he founded Emergent BioSolutions, which has since become a global leader in the field of biodefense. The company is known for its development of the Anthrax Vaccine Adsorbed (BioThrax) and other medical countermeasures.
Philanthropy
In addition to his work in biotechnology, El-Hibri is also known for his philanthropic efforts. He established the El-Hibri Foundation, which focuses on fostering interfaith dialogue and promoting social change.
Awards and Recognition
El-Hibri has received numerous awards for his contributions to the field of biotechnology, including the Ernst & Young Entrepreneur Of The Year Award in 2009.
Related Terms
- Biotechnology
- Vaccinology
- Emergent BioSolutions
- Anthrax Vaccine Adsorbed (BioThrax)
- El-Hibri Foundation
External links
- Medical encyclopedia article on Fuad El-Hibri
- Wikipedia's article - Fuad El-Hibri
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski